Invegrow Limited is a Malawi-based, women-led medical cannabis cultivation company specialising in the production of high-quality GACP certified flower for regulated markets. Established in 2009, the company operates large-scale cultivation facilities under quality control systems, with a strong focus on compliance, traceability and maximising the best of nature in its products.

Invegrow is committed to producing consistent, pharmaceutical-grade cannabis biomass and flower for use in medicinal formulations, extracts, and downstream pharmaceutical applications. The company works closely with licenced laboratories, regulatory authorities, and international partners to ensure products meet the standards required for export and therapeutic use.

With a disciplined approach to agronomy, genetics management, and post-harvest handling, Invegrow is positioned as a credible African supplier contributing to the global medical cannabis value chain, supporting patient access while advancing Malawi’s role in the regulated pharmaceutical sector.